Article
Upregulated CDKN2A expression may be an independent protective factor in Luminal-like breast cancer
2020-11-20
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Previous studies revealed that CDKN2A (cyclin-dependent kinase inhibitor 2A) functioned as a tumour suppressor in various types of malignant tumours. The aim of the study was to clarify the value of CDKN2A expression in the prognosis of breast cancer.<bold>Method: </bold> Using the Cancer Genome Atlas (TCGA) database, we compared CDKN2A mRNA levels between breas...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0abe2fe5-f8b1-5cde-964e-1d38abbcad66
- DOI
- 10.21203/rs.3.rs-56061/v2
